Purchase Order 75N94022P00348
- Not listed
- This is a firm fixed-price purchase order awarded by the Department of Health and Human Services National Institutes of Health Office of Logistics and Acquisition Operations to Quanterix Corporation, a life sciences company that provides ultra-sensitive digital biomarker detection technology. The contract, valued at $100,500.00, is for custom assay development services. Quanterix has received over $30 million in prior federal contracts from agencies including the National Institutes of Health,...
- This is a $19,170.11 firm-fixed-price purchase order contract awarded by the National Institute of Nursing Research, a civilian agency, to Quanterix Corporation, a life sciences company specializing in ultra-sensitive digital biomarker detection technology. The contract is for the provision of Quanterix's Simoa (single molecule array) instruments, assay kits, and research services, which enable the measurement of proteins and other biomarkers at unprecedented levels of sensitivity. This supports...
- This is a $119,614.50 firm-fixed-price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Institute on Aging to Quanterix Corporation, a life sciences company that provides ultra-sensitive digital biomarker detection technology. The award is for Quanterix's Simoa 4-plex and Singleplex 96-well Plate Assays, including reagents, buffers, and shipping, to support the NIH's biomedical research programs. This is an unset-aside, commercial...
- This firm fixed-price purchase order was awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency, to Quanterix Corporation for the supply of Neurology 4-Plex A Advantage Kits, SR-X Disc Kits, and Wash Buffers, with a total value of $30,152.63. The award has a completion date of July 31, 2024. Quanterix is a life sciences company that specializes in ultra-sensitive digital biomarker detection technology, and has provided various products and services...
- The Department of Health and Human Services, National Institutes of Health awarded a firm fixed price purchase order to Quanterix Corporation, a for-profit manufacturer of goods, for the N4PA SIMOA 2.0 ASSAY KIT. The $112,969.08 award, with an October 2020 completion date, was not set aside. Quanterix has received over $30 million in prior federal contracts from agencies like the NIH, Department of Veterans Affairs, and Department of Defense to supply its ultra-sensitive digital biomarker...
- This federal contract award, valued at $14,525.80, was issued by the National Institute of Child Health and Human Development (NICHD) to Quanterix Corporation, a life sciences company that specializes in ultra-sensitive digital biomarker detection technology. The contract, titled "NICHD - INFLIGHT V2 ADVANTAGE KIT", is a firm-fixed-price purchase order with a completion date of September 30, 2024. Quanterix has also been awarded an indefinite delivery contract (IDV) by the Department...
- The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $209,479.20 firm fixed-price purchase order to Quanterix Corporation, a life sciences company that provides ultra-sensitive digital biomarker detection technology. The contract is for the delivery of assay kits. Quanterix has previously received over $30 million in federal contracts from agencies including the National Institutes of Health, Department of Veterans Affairs, and...
- The National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services, awarded a $11,845 firm-fixed-price purchase order to Quanterix Corporation, a life sciences company specializing in ultra-sensitive digital biomarker detection technology. The contract is for a service agreement to provide the NICHD SR-X Biomarker Detection System equipment, which supports NICHD's biomedical research programs. Quanterix is the prime...
- This is a firm-fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to Quanterix Corporation. The contract, valued at $135,937.50, is for the provision of the Quanterix ELISA (Enzyme-Linked Immunosorbent Assay) System, which is used for ultra-sensitive digital biomarker detection. This contract was set aside for small businesses. Quanterix Corporation is a life sciences company specializing in advanced...
- This is a firm-fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Quanterix Corporation, a life sciences company specializing in ultra-sensitive digital biomarker detection technology. The contract, valued at $99,653.76, is for the supply of assay kits. This award is not designated as a set-aside contract. Quanterix is the prime contractor and has not reported any major subcontractors for this award. The company has a history of federal...
This is a $84,013.00 firm-fixed-price purchase order contract awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services, to Quanterix Corporation. The contract is for the development of custom assays, including reagents, for use on Quanterix's Simoa (single molecule array) instruments. This work supports NICHD's biomedical research programs. The contract was awarded without a set-aside designation, reflecting Quanterix's specialized capabilities in ultra-sensitive protein detection technology. Quanterix has an extensive history of providing products and services, including advanced instruments, assay kits, and custom assay development, to various federal agencies through both contracts and grants. This award is part of Quanterix's broader engagement with the federal government, which has included supporting initiatives such as the National Institutes of Health's Rapid Acceleration of Diagnostics (RADx) program for COVID-19 testing.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Calbindin D Assay Development for SRX instrument | 75N94022Q00098 | Department of Health and Human Services National Institutes of Health National Institute of Child Health and Human Development | Solicitation 1/1 | 4/25/22, 1:06 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Funding Only Action | ($8k) | 9/17/24 | |
| Not listed | Not listed | $92.5k | 5/5/22 |